• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,490.50 -218.02
( -0.28%)
Global Indices
Nasdaq
51,860.73 -306.69
(-0.59%)
Dow Jones
7,464.20 -14.49
(-0.19%)
Hang Seng
63,887.74 -2,947.80
(-4.41%)
Nikkei 225
10,542.79 -57.58
(-0.54%)
Forex
USD-INR
96.42 0.06
(0.07%)
EUR-INR
110.27 -0.10
(-0.09%)
GBP-INR
129.65 -0.46
(-0.35%)
JPY-INR
0.59 0.00
(-0.05%)

EQUITY - MARKET SCREENER

Eiko Lifesciences Ltd
Industry :  Chemicals
BSE Code
ISIN Demat
Book Value()
540204
INE666Q01016
47.0490317
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
19.66
70.52
EPS(TTM)
Face Value()
Div & Yield %
2.5
10
0
 

mmtc ltd
IndusInd Bank gains after Q1 deposits surpass 4 lakh crore
Jul 06,2026
Howver, Net advances fell 2.3% YoY to Rs 3,26,171 crore. CASA Ratio declined to 29.5% as on 30th June 2026 compared with 333,694 crore as on 30th June 2025.

On a sequential basis, total deposits increased 3.8% from Rs 3,99,931 crore as of 31 March 2026, while net advances rose 3.3% from Rs 3,15,871 crore during the same period.

Indusind Bank offers a wide range of products and services for individuals and corporates, including microfinance, personal loans, personal and commercial vehicle loans, credit cards and SME loans.

The bank reported a standalone net profit of Rs 532.71 crore in Q4 FY26, compared with a net loss of Rs 2,235.99 crore in the corresponding quarter last year. Total income rose 12.07% year-on-year (YoY) to Rs 12,711.77 crore in Q4 March 2026.